Practice
Featured experience
Bristol Myers Squibb €5 billion notes offering
We advised the underwriters on Bristol Myers Squibb Ireland’s inaugural euro issuance
BETA Technologies $1 billion IPO
The shares are listed on the New York Stock Exchange
Vistra $2 billion secured notes offering
The investment-grade notes are due 2028, 2030 and 2035
American Industrial Partners $1.5 billion acquisition of Global Cellulose Fibers
We are advising American Industrial Partners on the transaction
Dean Foods chapter 11 filing and $850 million DIP financing
Davis Polk is advising Southern Foods Group, LLC, Dean Foods Company and certain of their affiliates (collectively, “Dean…
Otter Tail Corporation $75 Million SEC-Registered At-The-Market Offering
Davis Polk advised the distribution agent on an SEC-registered at-the-market offering by Otter Tail Corporation of its…
Davis Polk Advises Clarivate Analytics plc on Its $1.850 Billion Refinancing
Davis Polk advised Clarivate Analytics plc in connection with the refinancing of its existing credit facility and unsecured…
Murray Energy chapter 11 restructuring and DIP financing
Davis Polk is advising an ad hoc group (the “Ad Hoc Group”) of prepetition superpriority secured lenders and post-petition…
McDermott International, Inc. $1.7 Billion Super-Priority Rescue Financing
Davis Polk advised an ad hoc group of term loan lenders in connection with a super-priority credit facility in the aggregate…
Davis Polk Advises Charles River Laboratories International, Inc. on Its $500 Million Notes Offering
Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of …
LYB International Finance III, LLC $1 Billion Guaranteed Notes Offering
Davis Polk advised the joint book-running managers on an SEC-registered offering by LYB International Finance III, LLC, a…
Black Hills $700 Million Senior Notes Offering
Davis Polk advised the representatives and joint book-running managers of an SEC-registered offering by Black Hills…
BioXcel Therapeutics, Inc. $18.9 Million Common Stock Offering
Davis Polk advised the underwriters in connection with the SEC-registered offering by BioXcel Therapeutics, Inc. of 2,303…
McKesson Corporation $4 Billion Revolving Credit Agreement
Davis Polk advised the joint lead arranger and bookrunner, and the administrative agent, in connection with a $4 billion…